Literature DB >> 24722442

Explaining the racial difference in AKI incidence.

Morgan E Grams1, Kunihiro Matsushita2, Yingying Sang2, Michelle M Estrella3, Meredith C Foster2, Adrienne Tin2, W H Linda Kao2, Josef Coresh4.   

Abstract

African Americans face higher risk of AKI than Caucasians. The extent to which this increased risk is because of differences in clinical, socioeconomic, or genetic risk factors is unknown. We evaluated 10,588 African-American and Caucasian participants in the Atherosclerosis Risk in Communities study, a community-based prospective cohort of middle-aged individuals. Participants were followed from baseline study visit (1996-1999) to first hospitalization for AKI (defined by billing code), ESRD, death, or December 31, 2010. African-American participants were slightly younger (61.7 versus 63.1 years, P<0.001), were more often women (64.5% versus 53.2%, P<0.001), and had higher baseline eGFR compared with Caucasians. Annual family income, education level, and prevalence of health insurance were lower among African Americans than Caucasians. The unadjusted incidence of hospitalized AKI was 7.4 cases per 1000 person-years among African Americans and 5.8 cases per 1000 person-years among Caucasians (P=0.002). The elevated risk of AKI among African Americans persisted after adjustment for demographics, cardiovascular risk factors, kidney markers, and time-varying number of hospitalizations (adjusted hazard ratio, 1.20; 95% confidence interval [95% CI], 1.01 to 1.43; P=0.04); however, accounting for differences in income and/or insurance by race attenuated the association (P>0.05). High-risk APOL1 variants did not associate with AKI among African Americans (demographic-adjusted hazard ratio, 1.07; 95% CI, 0.69 to 1.65; P=0.77). In summary, the higher risk of AKI among African Americans may be related to disparities in socioeconomic status.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722442      PMCID: PMC4116065          DOI: 10.1681/ASN.2013080867

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

1.  Racial/Ethnic differences in Medicare experiences and immunization: the role of disease burden.

Authors:  Nate Orr; Marc N Elliott; Q Burkhart; Amelia Haviland; Robin M Weinick
Journal:  Med Care       Date:  2013-09       Impact factor: 2.983

Review 2.  Influence of race, ethnicity and socioeconomic status on kidney disease.

Authors:  Rachel E Patzer; William M McClellan
Journal:  Nat Rev Nephrol       Date:  2012-06-26       Impact factor: 28.314

3.  Genetic variation in APOL1 associates with younger age at hemodialysis initiation.

Authors:  Zahra Kanji; Camille E Powe; Julia B Wenger; Chunmei Huang; Elizabeth Ankers; Dorothy A Sullivan; Gina Collerone; Neil R Powe; Marcello Tonelli; Ishir Bhan; Andrea J Bernhardy; Salvatore Dibartolo; David Friedman; Giulio Genovese; Martin R Pollak; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

4.  Racial/ethnic disparities in Medicare Part D experiences.

Authors:  Amelia M Haviland; Marc N Elliott; Robert Weech-Maldonado; Katrin Hambarsoomian; Nate Orr; Ron D Hays
Journal:  Med Care       Date:  2012-11       Impact factor: 2.983

5.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

6.  Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Claudine T Jurkovitz; Suying Li; Keith C Norris; Georges Saab; Andrew S Bomback; Adam T Whaley-Connell; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

7.  Lifetime incidence of CKD stages 3-5 in the United States.

Authors:  Morgan E Grams; Eric K H Chow; Dorry L Segev; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-04-06       Impact factor: 8.860

8.  Lower socioeconomic status and disability among US adults with chronic kidney disease, 1999-2008.

Authors:  Laura C Plantinga; Kirsten L Johansen; Dean Schillinger; Neil R Powe
Journal:  Prev Chronic Dis       Date:  2011-12-15       Impact factor: 2.830

9.  Incidence and predictors of end stage renal disease among low-income blacks and whites.

Authors:  Loren Lipworth; Michael T Mumma; Kerri L Cavanaugh; Todd L Edwards; T Alp Ikizler; Robert E Tarone; Joseph K McLaughlin; William J Blot
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

View more
  44 in total

1.  Acute Kidney Injury Among Older Patients Undergoing Coronary Angiography for Acute Myocardial Infarction: The SILVER-AMI Study.

Authors:  John A Dodson; Alexandra Hajduk; Jeptha Curtis; Mary Geda; Harlan M Krumholz; Xuemei Song; Sui Tsang; Caroline Blaum; Paula Miller; Chirag R Parikh; Sarwat I Chaudhry
Journal:  Am J Med       Date:  2019-06-04       Impact factor: 4.965

2.  Racial differences in acute kidney injury of hospitalized adults with diabetes.

Authors:  Nestoras N Mathioudakis; Monica Giles; Hsin-Chieh Yeh; Carlton Haywood; Raquel C Greer; Sherita Hill Golden
Journal:  J Diabetes Complications       Date:  2016-04-02       Impact factor: 2.852

3.  AKI in Hospitalized Patients with and without COVID-19: A Comparison Study.

Authors:  Molly Fisher; Joel Neugarten; Eran Bellin; Milagros Yunes; Lindsay Stahl; Tanya S Johns; Matthew K Abramowitz; Rebecca Levy; Neelja Kumar; Michele H Mokrzycki; Maria Coco; Mary Dominguez; Kalyan Prudhvi; Ladan Golestaneh
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

4.  Race, class, and AKI.

Authors:  Sevag Demirjian
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

5.  Race, APOL1 Risk, and eGFR Decline in the General Population.

Authors:  Morgan E Grams; Casey M Rebholz; Yuan Chen; Andreea M Rawlings; Michelle M Estrella; Elizabeth Selvin; Lawrence J Appel; Adrienne Tin; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

6.  Trends and outcomes of sepsis hospitalizations complicated by acute kidney injury requiring hemodialysis.

Authors:  Uvesh Mansuri; Achint Patel; Harshil Shah; Kinsuk Chauhan; Priti Poojary; Aparna Saha; Mihir Dave; Arpita Hazra; Tushar Mishra; Narender Annapureddy; Girish Nadkarni; Lili Chan
Journal:  J Crit Care       Date:  2016-12-02       Impact factor: 3.425

Review 7.  A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury.

Authors:  Morgan E Grams; Yingying Sang; Shoshana H Ballew; Ron T Gansevoort; Heejin Kimm; Csaba P Kovesdy; David Naimark; Cecilia Oien; David H Smith; Josef Coresh; Mark J Sarnak; Benedicte Stengel; Marcello Tonelli
Journal:  Am J Kidney Dis       Date:  2015-05-02       Impact factor: 8.860

8.  Racial and health insurance disparities in pediatric acute kidney injury in the USA.

Authors:  Erica C Bjornstad; Stephen W Marshall; Amy K Mottl; Keisha Gibson; Yvonne M Golightly; Anthony Charles; Emily W Gower
Journal:  Pediatr Nephrol       Date:  2020-01-29       Impact factor: 3.714

Review 9.  Burden, access, and disparities in kidney disease.

Authors:  Deidra C Crews; Aminu K Bello; Gamal Saadi
Journal:  J Nephrol       Date:  2019-02       Impact factor: 3.902

Review 10.  Genomics in CKD: Is This the Path Forward?

Authors:  Girish N Nadkarni; Carol R Horowitz
Journal:  Adv Chronic Kidney Dis       Date:  2016-03       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.